What is the initial approach to treating hyponatraemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Approach to Treating Hyponatraemia

The initial approach to treating hyponatraemia depends critically on symptom severity and volume status: severely symptomatic patients require immediate 3% hypertonic saline to correct sodium by 6 mmol/L over 6 hours, while asymptomatic patients should be managed based on their volume status with fluid restriction for euvolaemic/hypervolaemic states or isotonic saline for hypovolaemic states. 1

Immediate Assessment

Determine symptom severity first - this dictates urgency of treatment 1:

  • Severe symptoms (seizures, coma, altered mental status, cardiorespiratory distress) = medical emergency requiring immediate hypertonic saline 1, 2
  • Mild symptoms (nausea, headache, confusion) = less urgent, guided by volume status 1
  • Asymptomatic = treat underlying cause, avoid rapid correction 1, 3

Assess volume status through physical examination 1:

  • Hypovolaemic signs: orthostatic hypotension, dry mucous membranes, decreased skin turgor, flat neck veins 1
  • Euvolaemic: no edema, normal blood pressure, normal skin turgor 1
  • Hypervolaemic signs: peripheral edema, ascites, jugular venous distention, pulmonary congestion 1

Treatment Algorithm Based on Symptom Severity

For Severe Symptomatic Hyponatraemia (Medical Emergency)

Administer 3% hypertonic saline immediately 1, 2, 3:

  • Give as 100-150 mL IV bolus over 10 minutes, can repeat up to 3 times at 10-minute intervals 1
  • Target: increase sodium by 6 mmol/L over first 6 hours OR until symptoms resolve 1
  • Critical safety limit: never exceed 8 mmol/L correction in 24 hours to prevent osmotic demyelination syndrome 1, 2
  • Monitor serum sodium every 2 hours during initial correction 1

For Asymptomatic or Mildly Symptomatic Hyponatraemia

Treatment is determined by volume status 1:

Hypovolaemic hyponatraemia 1:

  • Discontinue diuretics immediately 1
  • Administer isotonic saline (0.9% NaCl) for volume repletion 1
  • Urine sodium <30 mmol/L predicts good response to saline (positive predictive value 71-100%) 1

Euvolaemic hyponatraemia (SIADH) 1, 3:

  • First-line: Fluid restriction to 1 L/day 1
  • If no response after 24-48 hours, add oral sodium chloride 100 mEq three times daily 1
  • Second-line options if resistant: urea or tolvaptan 3
  • Note: Almost half of SIADH patients do not respond to fluid restriction alone 3

Hypervolaemic hyponatraemia (heart failure, cirrhosis) 1:

  • Fluid restriction to 1-1.5 L/day for sodium <125 mmol/L 1
  • Discontinue diuretics temporarily if sodium <125 mmol/L 1
  • Consider albumin infusion in cirrhotic patients 1
  • Avoid hypertonic saline unless life-threatening symptoms present - it worsens edema and ascites 1

Specific Sodium Level Thresholds

Sodium 126-135 mmol/L 4:

  • Continue diuretic therapy with close electrolyte monitoring 4
  • Do NOT water restrict 4

Sodium 121-125 mmol/L 4:

  • International opinion: continue diuretics 4
  • More cautious approach: stop or reduce diuretics 4
  • If creatinine elevated: stop diuretics and give volume expansion 4

Sodium ≤120 mmol/L 4:

  • Stop diuretics immediately 4
  • Most patients should undergo volume expansion with colloid (haemaccel, gelofusine, voluven) or saline 4
  • Critical: avoid increasing sodium by >12 mmol/L per 24 hours 4

Essential Initial Workup

Obtain these tests immediately 1:

  • Serum osmolality (to exclude pseudohyponatraemia) 1
  • Urine osmolality and urine sodium concentration 1
  • Serum creatinine and electrolytes 1
  • Thyroid-stimulating hormone (to exclude hypothyroidism) 1
  • Serum uric acid (<4 mg/dL suggests SIADH with 73-100% positive predictive value) 1

Critical Correction Rate Guidelines

Standard patients: 4-8 mmol/L per day, maximum 8 mmol/L in 24 hours 1

High-risk patients (advanced liver disease, alcoholism, malnutrition, prior encephalopathy): 4-6 mmol/L per day, maximum 8 mmol/L in 24 hours 1, 2

Exceeding these limits risks osmotic demyelination syndrome - a devastating neurological complication causing dysarthria, dysphagia, quadriparesis, or death 1, 2

Common Pitfalls to Avoid

  • Never use fluid restriction in hypovolaemic hyponatraemia - this worsens the condition 1
  • Never use hypertonic saline in hypervolaemic hyponatraemia without severe symptoms - worsens fluid overload 1
  • Never correct chronic hyponatraemia faster than 8 mmol/L in 24 hours - risks osmotic demyelination 1, 2
  • Never ignore mild hyponatraemia (130-135 mmol/L) - associated with increased falls, fractures, and mortality 1, 2
  • In neurosurgical patients, distinguish SIADH from cerebral salt wasting - they require opposite treatments (fluid restriction vs. volume replacement) 1

Special Consideration: Cirrhotic Patients

Hyponatraemia in cirrhosis requires particularly cautious management 4, 1:

  • Water restriction has controversial benefit and may worsen effective hypovolaemia 4
  • Some experts advocate plasma expansion rather than water restriction 4
  • Hyponatraemia increases risk of hepatorenal syndrome, spontaneous bacterial peritonitis, and hepatic encephalopathy 1
  • Avoid rapid correction - these patients are at highest risk for osmotic demyelination 1

References

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.